tiprankstipranks
Trending News
More News >

Adherium Issues Stock Appreciation Rights to Employees

Story Highlights
  • Adherium Limited issued 2,000,000 stock appreciation rights under an employee scheme.
  • These securities are unquoted and restricted, aligning with Adherium’s retention strategy.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Adherium Issues Stock Appreciation Rights to Employees

Don’t Miss TipRanks’ Half-Year Sale

The latest announcement is out from Adherium Ltd. ( (AU:ADR) ).

Adherium Limited announced the issuance of 2,000,000 stock appreciation rights under an employee incentive scheme. These unquoted securities are subject to transfer restrictions and are not listed on the ASX until the restrictions are lifted, reflecting the company’s strategy to incentivize and retain key personnel.

More about Adherium Ltd.

Adherium Limited operates in the healthcare industry, focusing on developing digital health technologies. The company primarily offers solutions for monitoring and managing respiratory conditions, aiming to improve patient outcomes and reduce healthcare costs.

Average Trading Volume: 1,127,531

Technical Sentiment Signal: Sell

Current Market Cap: A$5.31M

Learn more about ADR stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1